Prognostic markers in diffuse large B-cell lymphoma.
Delabie
Jan
J
Department of Pathology, Oslo University Hospital and University of Oslo, Oslo, Norway. jan.delabie@medisin.uio.no
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism*; D019013:CD40 Antigens / Q000378:metabolism*; D006801:Humans; D007167:Immunotherapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000378:metabolism*; D011379:Prognosis
D014408:Biomarkers, Tumor; D019013:CD40 Antigens